Glyoxamide is a second-generation sulfonylurea antidiabetic agent primarily utilized in the management of type 2 diabetes mellitus. By binding to SUR1 subunits of ATP-sensitive potassium channels in pancreatic… Read more
Glyoxamide is a second-generation sulfonylurea antidiabetic agent primarily utilized in the management of type 2 diabetes mellitus. By binding to SUR1 subunits of ATP-sensitive potassium channels in pancreatic beta cells, this medication stimulates insulin secretion to improve glycemic control. The product range for this compound includes essential analytical tools such as glyoxamide impurities, metabolites like N-desmethylglyoxamide, and stable isotope-labelled standards such as [U-13C]glyoxamide. These pharmaceutical reference standards are critical for laboratories conducting rigorous impurity profiling, method validation, and quality control during drug development and regulatory assessment. By providing high-quality, characterized materials, these products enable accurate quantitative analysis and the detection of degradation products, ensuring compliance with safety and purity requirements throughout the lifecycle of the active pharmaceutical ingredient.